Shanghai Pharmaceuticals (02607.HK): Ammonia ring acid injection passed the consistency evaluation of generic drugs.

Wisdom Financial News APP, Shanghai Pharmaceuticals (02607.HK) announced that recently, its subsidiary Shanghai Xinyi Jinzhu Pharmaceutical Co., Ltd. (hereinafter referred to as "Xinyi Jinzhu") received the "Drug Supplementary Application Approval Notice" (Notice Number: 2025B03210) issued by the National Medical Products Administration (hereinafter referred to as "NMPA") for the injection of amphotericin B (hereinafter referred to as "the drug"), the drug has passed the evaluation of the consistency of generic drug quality and efficacy.